Table 1 Demographics and clinical characteristics of PTC patients (n = 378)
From: A nomogram to predict skip metastasis in papillary thyroid cancer
Variable | Results |
|---|---|
Sex | |
Male | 114 (30.16%) |
Female | 264 (69.84%) |
Age | |
≧ 55 years | 42 (11.11%) |
< 55 years | 336 (88.89%) |
Age (mean ± SD, years) | 39.96 ± 11.73 |
Multifocality | |
Yes | 84 (22.22%) |
No | 294 (77.78%) |
Bilaterality | |
Yes | 117 (30.95%) |
No | 261 (69.05%) |
Primary tumor location | |
Upper | 92 (24.34%) |
Middle | 180 (47.62%) |
Lower | 106 (28.04%) |
HT | |
Yes | 87 (23.16%) |
No | 291 (76.98%) |
ETE | |
Yes | 69(18.25%) |
No | 309(81.75%) |
Capsule invasion | |
Yes | 95 (25.13%) |
No | 283(74.87%) |
Tumor extension | |
T1 | 219 (57.94%) |
T2 | 48 (12.70%) |
T3 | 83 (21.96%) |
T4 | 28 (7.41%) |
Primary tumor size ≦ 1 cm | |
Yes | 142 (37.57%) |
No | 236 (62.43%) |
Total tumor size (mean ± SD, cm) | 1.56 ± 0.96 |
Skip metastasis | |
Yes | 44(11.6%) |
No | 334(88.4%) |
Number of central dissected lymph nodes | 7.51 ± 5.08 |
Number of lateral dissected lymph nodes | 18.25 ± 12.59 |